84 ROLE OF uCTX-I uCTX-II GLUCOSAMINE, CHONDROITINSULPHATE AND TYPE II COLLAGEN IN OSTEOARTHRITIS FOLLOW-UP: AN ITALIAN OBSERVATIONAL STUDY  by Scarpellini, M. et al.
S50 Osteoarthritis and Cartilage Vol. 16 Supplement 4
This study examined whether enhancement of the endogenous cannabi-
noid level by local administration of the fatty acid amide hydrolase (FAAH)
inhibitor URB597 into the knee joint could modulate joint nociception and
consequently pain transmission in this animal model of naturally occurring
osteoarthritis in the guinea pigs.
Methods: Guinea pigs (9 months of age) were deeply anaesthetised
with ethyl carbamate (urethane; 2mg×kg−1 i.p.). Joint nociception was
objectively measured in the animals by electrophysiological recordings
from knee joint primary afferents in response to normal rotation and
noxious hyper-rotation of the joint. Rotations were done both before and
after close intra-arterial injection of URB597 (30 ug; 100 ul bolus). The
number of action potentials per movement were determined 1, 3, 5, 7
and 10 minutes after the URB597 injection.
Recording of a typical single knee joint afferent in response to noxious
rotation. Close intra arterial injection of the fatty acid amid hydrolase
inhibitor (FAAH) URB597 reduces ﬁring frequency of the ﬁbre.
Results: A single injection of URB597 caused the afferent ﬁring rate to
be signiﬁcantly reduced during normal rotation and during hyper-rotation
of guinea pig knee joint. The desensetizing effect was maximal 5 minutes
after URB597 application. About 30% of the recorded afferents showed
spontaneous activity, of which URB597 signiﬁcantly reduced the ﬁring rate
in the majority. Blockage of peripheral CB1 receptors by co-administration
of the selective CB1 receptor antagonist AM251 (10−9 mol) abolished the
antinociceptive effect of URB597, conﬁrming that the effect is mediated
via the CB1 receptor.
Recording of a spontaneous active joint afferent. URB597 reduces ﬁring
frequency and subsequently inhibits tonically nociceptive transmission.
Conclusions: The ﬁndings indicate that close intra-arterial injection of
URB597 into the osteoarthritic knee joint of Dunkin Hartley guinea pigs
alleviated peripheral sensitization of knee joint afferents and consequently
reduced pain transmission during joint movement. In addition, a reduction
of spontaneous activity reﬂects a corresponding decrease of tonically
transmitted nociceptive information. The results show that a local increase
of the endocannabinoid level has a direct desensetizing effect on afferent
nerve activity in the guinea pig knee joint, providing new evidence for
the role of the endocannabinoid system in peripheral pain modulation.
Targeting cannabinoid metabolizing enzymes in the peripheral nervous
system could offer novel therapeutic approaches for efﬁcient treatment
of osteoarthritis pain without psychotropic side effects accompanied with
systemic cannabinoid administration.
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Purpose: To examine the association of serum cartilage oligomeric
matrix protein (COMP) and hyaluronan (HA) levels with the estimation
of articular damage and disease progression in patients with knee os-
teoarthritis (OA).
Methods: A total of 134 patients with available sera and evidence of
radiographic knee OA were examined. Biological markers were measured
at baseline, and following 3, 6 and 12 months. COMP was quantiﬁed by
enzyme-linked immunosorbent assay (ELISA) and HA was measured by
inhibition binding assay. Knee anteroposterior radiographs under weight
bearing were obtained at baseline, following 12 and 24 months. OA stage
was assessed by Kellgren and Lawrence grade (K-L grade) and joint
space width (JSW) was also measured. Clinical signs and symptoms
were interviewed and assessed by Lequesne’s index and visual analogue
scale (VAS) score.
Results: COMP did not show signiﬁcant correlation with gender and
obesity. COMP of K-L grade 3 was higher than any other grade, however
there was not any correlation with clinical evaluation. HA was slightly
higher in female and showed signiﬁcant correlation with clinical scores,
however did not show correlation with radiological severity. Baseline and
average COMP levels were higher in the progressive group which showed
radiological joint space narrowing over 1mm in 12 months or 24 months,
than in the non-progressive group which showed narrowing within 1mm
for a following period.
Conclusions: COMP elevation of K-L grade 3 may indicate high turnover
of cartilage metabolism according to OA progression, and its decrease
in grade 4 may reﬂect loss of cartilage amount or low turnover of
cartilage tissue in the most advanced stage. Since there was signiﬁcant
correlation between elevation of serum COMP and joint space narrowing,
COMP could predict rapid OA progression. Correlation of HA with clinical
evaluation suggests that clinical severity of OA could be affected by
synovial inﬂammation rather than cartilage destruction.
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Purpose: To determine relationship between disease activity, systemic
markers of cartilage degradation, urinary C-terminal cross linking telopep-
tides of type II collagen (uCTX-II), and bone degradation, urinary
C-terminal cross linking telopeptides of type I collagen (uCTX-I), structural
progression of osteoarthritis (OA) and potential therapeutic efﬁcacy of
type II collagen in combination with glucosamine and chondroitinsulphate.
Methods: An observational retrospective study, 1 year follow-up, on
104 patients with osteoarthritis (nodular osteoarthritis of the hand, HOA,
erosive osteoarthritis of the hand, EOA, osteoarthritis of the knee or
hip) who were treated with glucosamine and chondroitinsulphate (GC)
or glucosamine, chondroitinsulphate and collagen type II (GCC). The
following information was collected at entry: demographics, BMI, charac-
teristics of OA, patient global assessment (VAS), C-terminal crosslinking
telopeptides of collagen types I (uCTX-I) and II (uCTX-II) and radiographs.
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After six months: VAS, uCTX-I and uCTX-II. After one year: VAS, uCTX-I,
uCTX-II and radiographs.
Results: After 6 months and 1 year of treatment VAS, uCTX-I and uCTX-
II mean values were signiﬁcantly lower than the baseline. 57 were treated
with GCC and 47 with GC. The group that received GCC showed a similar
VAS mean value after 6 months and 1 year when compared with the group
treated with GC. uCTX-I and uCTX-II mean level was lower in the group
treated with GCC (p< 0.05). Radiological score (Kellgren and Lawrence
summarized score for hands) after 1 year showed a reduced progression
compared to the baseline in the hand osteoarthritis group, especially
after GCC treatment (p< 0.05). Finally, uCTX-I has better correlation with
radiological score and with GC in the EOA subgroup (Pearson index:
R=0.44).
Conclusions: (a) uCTX-I and uCTX-II proved to be useful biomarkers
in OAmonitoring; (b) uCTX-I is better correlated with hand EOA and
could represent a potential further marker to asses the evolution of EOA
bone damage; (c) glucosamine and chondroitinsulphate slow down OA
progression; (d) ﬁnally COLLII could represent a further protective factor
in OA cartilage.
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Purpose: To determine the proﬁle of Coll2−1, Coll2−1NO2 and myeloper-
oxydase (MPO) serum concentrations in experimental knee OA induced
in the dog by transection of the anterior cruciate ligament
Methods: Surgical transection of the ACL of the right knee was performed
on 16 adult crossbred dogs. The dogs were sacriﬁced 8 weeks after
the surgical procedure. Coll2−1, Coll2−1NO2 and MPO were measured
by speciﬁc immunoassays in 16 dogs at baseline and every 2 weeks
during the 8 weeks. The results were expressed as median (range). The
Friedman test estimated the variation for each biomarker every 2 weeks
during the 8 weeks.
Results: Immunostainings with D3 and D37, the antiserum recognizing
Coll2−1 and Coll2−1NO2, respectively, labelled extracellular matrix in the
superﬁcial layer of ﬁbrillated cartilage. After the transection of the ACL,
the concentration of 3 biomarkers increased signiﬁcantly (Friedman test:
Coll2−1, Coll2−1NO2 and MPO: p< 0.001). The concentrations of Coll2−1
and MPO were signiﬁcantly increased at week 2 compared to baseline
[Coll2−1 baseline: 281.57 (131.02–384.67) nM vs Coll2−1 week 2: 345.52
(181.15–589.25) nM (p< 0.01) and MPO baseline: 5.16 (<0.4−14.7) ng/ml
vs MPO week 2: 14.54 (3.28−31.50) ng/ml (p< 0.001)] and remained sta-
ble until week 8 [Coll2−1 week 8: 318.89 (117.95–492.28) nM and MPO
week 8: 11.55 (2.87−42.94) ng/ml]. The Coll2−1NO2 concentration in-
creased signiﬁcantly at weeks 6 and 8 compared to baseline [Coll2−1NO2
baseline: 0.54 (0.29−1.48) nM vs Coll2−1NO2 week 6: 0.64 (0.40−1.9)
nM (p< 0.001) vs week 8: 0.61 (0.37−1.79) nM]. The global macroscopic
score correlated positively with the 8-week changes of Coll2−1 (r = 0.57,
p = 0.02). No similar correlations were found for Coll2−1NO2 and MPO.
Finally, there was a positive correlation between the 4-week changes of
Coll2−1 and Coll2−1NO2 and the microscopic score of cartilage lesion
severity (condyles; Coll2−1: r = 0.56, p = 0.025 and Coll2−1NO2: r = 0.52,
p = 0.049). No similar correlations were found for MPO.
Conclusions: These ﬁndings suggest that Coll2−1 is a relevant marker
for the detection of early structural changes in OA dogs. Interestingly,
MPO and Coll2−1NO2 are increased in OA dogs indicating that an
oxidative stress occurs in this OA model.
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Purpose: Aggrecan proteolysis is an early key event in arthritis releasing
fragments into the synovial ﬂuid (SF). In understanding the mechanisms
of cartilage degradation and identifying OA biomarkers detailed aggrecan
fragment patterns from human joint diseases and disease stages are
helpful. This can be obtained by Western blot analysis. We have analyzed
how different preparation methods for SF aggrecan fragments affect
the puriﬁcation levels, sulfated glycosaminoglycan (sGAG) yields and
Western blot immuno patterns.
Methods: Aggrecan fragments were puriﬁed from a human SF-pool
(n> 100, from OA and knee injuries) by: (1) Dissociative and associa-
tive CsCl density gradient centrifugation collecting D1 and A1 fractions;
(2) Boiling SF and collecting supernatant after centrifugation; (3) Blue
SepharoseTM chromatography at pH 7 collecting the non binding ﬂow-
through; (4) Anion chromatography (Mono-QTM or Q-SepharoseTM) at
pH 5 collecting the 2M or 3M NaCl batch eluates. Puriﬁed aggrecan sam-
ples were deglycosylated, separated by SDS-PAGE, transferred to PVDF
membranes and probed with antibodies against aggrecanase generated
neo-epitopes (ARGS, TEGE, SELE, KEEE and LGQR) or against G1-
and G3-domains. sGAG was analyzed by Alcian Blue precipitation, total
protein by BCA method.
Table 1. Puriﬁcation of aggrecan fragments from a human SF-pool
Puriﬁcation method Puriﬁed sample sGAG recovery
(%)
Puriﬁcation level (mg
sGAG/mg protein)
None SF 100 2−6.6
Boiled SF Supernatant 63 79
Blue Sepharose Flow through 67 28
Blue Sepharose & Mono-Q 3M elute 75 95
Blue Sepharose & Q-Sepharose 2M elute 68 925
Density centrifugation D1 86 5770
A1 92 732
Figure 1. Human synovial ﬂuid aggrecan fragments were puriﬁed by
(1) Blue Sepharose and Q-Sepharose; (2) Blue Sepharose and Mono-Q;
(3) Blue Sepharose; (4) D1 fraction; (5) Boiling SF, and analyzed by anti-
ARGS Western blot.
Results: The sGAG/total protein ratio was used as a measure of pu-
riﬁcation level of sGAG containing aggrecan fragments. The highest
puriﬁcation level was in the D1 fraction (Table 1). Blue Sepharose
or Q-Sepharose methods resulted in low puriﬁcation levels (30−40 mg
sGAG/mg protein), while a combination resulted in 20−30 times higher
puriﬁcation. A1 fraction showed similar puriﬁcation level, while puriﬁcation
with Blue Sepharose combined with Mono-Q, or boiling the SF resulted
in modest puriﬁcation levels (80–100mg sGAG/mg protein). Using the
chromatography and CsCl density centrifugation methods the sGAG
recoveries from SF samples were high, and highest yields were obtained
in D1 and A1 samples.
The Western blot immuno pattern of 2M and 3M eluates of anion
chromatography, exempliﬁed by the ARGS immuno pattern (Fig. 1), was
